In March 2019, WHO issued “Consolidated guidelines on drug-resistant tuberculosis treatment”
Please find these via the link: https://www.who.int/tb/publications/2019/consolidated-guidelines-drug-resistant-TB-treatment/en/
These consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB and replace all previous WHO guidelines on DR-TB. They include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and multidrug- and rifampicin-resistant (MDR/RR-TB), including longer and shorter regimens for MDR/RR-TB, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
Also By
- Peer support for adult social care in prisons in England and Wales: a mixed-methods rapid evaluation
- Professor Sir Chris Whitty wants to hear from you! Have your say on health research with people in prison and on probation in England
- Register now: International Outbreak Management in Secure Settings Webinar
Please Sign in (or Register) to view further.